Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of Tuesday, October 6, 2026.
EARNINGS PER SHARE (EPS)
N/A
Market Cap
$227.60M
Earnings Per Share (EPS)
-3.17
TTM Avg
-5.64
3Y Avg
-13.77
5Y Avg
-18.37
Market Cap
$225.24M
Earnings Per Share (EPS)
-0.45
TTM Avg
-0.52
3Y Avg
-0.50
5Y Avg
-0.51
Market Cap
$231.37M
Earnings Per Share (EPS)
-0.22
TTM Avg
-1.13
3Y Avg
-1.09
5Y Avg
-1.70
Market Cap
$231.77M
Earnings Per Share (EPS)
-1.54
TTM Avg
-1.32
3Y Avg
-0.98
5Y Avg
-0.74
Market Cap
$232.72M
Earnings Per Share (EPS)
-0.57
TTM Avg
-0.79
3Y Avg
-0.77
5Y Avg
-0.98
Market Cap
$220.93M
Earnings Per Share (EPS)
-0.99
TTM Avg
-1.25
3Y Avg
-1.31
5Y Avg
-1.33
Market Cap
$235.08M
Earnings Per Share (EPS)
3.28
TTM Avg
3.72
3Y Avg
4.14
5Y Avg
3.92
Market Cap
$235.66M
Earnings Per Share (EPS)
-0.11
TTM Avg
-0.18
3Y Avg
-0.30
5Y Avg
-0.87
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vogenx Inc. (VOGX) | $227.91M | N/A | N/A | N/A | N/A |
| Biodesix, Inc. (BDSX)vs › | $227.60M | -3.17 | -5.64 | -13.77 | -18.37 |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $225.24M | -0.45 | -0.52 | -0.50 | -0.51 |
| MacroGenics, Inc. (MGNX)vs › | $231.37M | -0.22 | -1.13 | -1.09 | -1.70 |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $231.77M | -1.54 | -1.32 | -0.98 | -0.74 |
| InflaRx N.V. (IFRX)vs › | $232.72M | -0.57 | -0.79 | -0.77 | -0.98 |
| Profound Medical Corp. (PROF)vs › | $220.93M | -0.99 | -1.25 | -1.31 | -1.33 |
| Utah Medical Products, Inc. (UTMD)vs › | $235.08M | 3.28 | 3.72 | 4.14 | 3.92 |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.66M | -0.11 | -0.18 | -0.30 | -0.87 |
| SIGA Technologies, Inc. (SIGA)vs › | $235.97M | -0.04 | 0.58 | 0.64 | 0.70 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
